 Michael Aubrey
Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transplantation, Haploidentical | 4 | 2024 | 22 | 0.800 |
Why?
| | HLA-DRB1 Chains | 4 | 2016 | 112 | 0.620 |
Why?
| | Epitopes | 4 | 2016 | 479 | 0.540 |
Why?
| | HLA-B Antigens | 3 | 2024 | 62 | 0.470 |
Why?
| | HLA Antigens | 5 | 2024 | 240 | 0.450 |
Why?
| | Vimentin | 2 | 2016 | 52 | 0.390 |
Why?
| | Graft vs Host Disease | 3 | 2024 | 252 | 0.370 |
Why?
| | Peptides, Cyclic | 2 | 2016 | 259 | 0.350 |
Why?
| | Arthritis, Rheumatoid | 3 | 2016 | 1167 | 0.330 |
Why?
| | Graft Rejection | 2 | 2024 | 624 | 0.300 |
Why?
| | Genetic Predisposition to Disease | 5 | 2016 | 2426 | 0.250 |
Why?
| | Alleles | 6 | 2024 | 891 | 0.240 |
Why?
| | Blood Group Incompatibility | 1 | 2024 | 15 | 0.220 |
Why?
| | ABO Blood-Group System | 1 | 2024 | 51 | 0.220 |
Why?
| | Fetomaternal Transfusion | 1 | 2023 | 11 | 0.210 |
Why?
| | HLA-C Antigens | 1 | 2022 | 35 | 0.190 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 2022 | 87 | 0.180 |
Why?
| | Receptors, KIR | 2 | 2022 | 98 | 0.180 |
Why?
| | Recurrence | 1 | 2024 | 1060 | 0.170 |
Why?
| | Transplantation Conditioning | 2 | 2020 | 170 | 0.170 |
Why?
| | Evolution, Molecular | 1 | 2024 | 493 | 0.170 |
Why?
| | Tacrolimus | 1 | 2020 | 199 | 0.150 |
Why?
| | Pulmonary Alveolar Proteinosis | 1 | 2019 | 17 | 0.150 |
Why?
| | Islets of Langerhans | 3 | 1994 | 803 | 0.150 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 1079 | 0.150 |
Why?
| | Pregnancy Complications | 1 | 2023 | 527 | 0.140 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2018 | 24 | 0.140 |
Why?
| | Heart Transplantation | 1 | 2024 | 754 | 0.140 |
Why?
| | Donor Selection | 1 | 2018 | 77 | 0.140 |
Why?
| | HLA-DR Antigens | 2 | 2020 | 228 | 0.120 |
Why?
| | Autoimmune Diseases | 1 | 2019 | 460 | 0.110 |
Why?
| | Tissue Donors | 1 | 2018 | 425 | 0.110 |
Why?
| | Insulin | 3 | 1994 | 2409 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 1994 | 852 | 0.110 |
Why?
| | Peptides | 2 | 2016 | 985 | 0.100 |
Why?
| | International Cooperation | 1 | 2011 | 198 | 0.090 |
Why?
| | Cyclophosphamide | 2 | 2022 | 247 | 0.090 |
Why?
| | Cell Division | 1 | 1992 | 794 | 0.090 |
Why?
| | Heart Failure | 1 | 2024 | 2236 | 0.090 |
Why?
| | Algorithms | 1 | 2018 | 1704 | 0.080 |
Why?
| | Humans | 23 | 2024 | 137585 | 0.080 |
Why?
| | Graft Survival | 2 | 2024 | 535 | 0.080 |
Why?
| | Histocompatibility Testing | 2 | 2020 | 126 | 0.080 |
Why?
| | Protein Binding | 2 | 2016 | 2224 | 0.080 |
Why?
| | Gene Frequency | 3 | 2019 | 521 | 0.080 |
Why?
| | Arachis | 1 | 2010 | 112 | 0.080 |
Why?
| | Immunoglobulin E | 1 | 2010 | 342 | 0.070 |
Why?
| | Peanut Hypersensitivity | 1 | 2010 | 146 | 0.070 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2024 | 622 | 0.070 |
Why?
| | Amino Acids | 1 | 2011 | 497 | 0.070 |
Why?
| | Mycobacterium Infections | 1 | 1987 | 63 | 0.070 |
Why?
| | Immunoglobulin G | 1 | 2010 | 893 | 0.060 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2022 | 367 | 0.060 |
Why?
| | Cricetinae | 3 | 1994 | 289 | 0.060 |
Why?
| | Middle Aged | 7 | 2024 | 33479 | 0.060 |
Why?
| | Retrospective Studies | 4 | 2024 | 15657 | 0.060 |
Why?
| | Haplotypes | 3 | 2014 | 494 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2011 | 3556 | 0.050 |
Why?
| | HLA-DP beta-Chains | 1 | 2024 | 86 | 0.050 |
Why?
| | Genotype | 2 | 2022 | 1916 | 0.050 |
Why?
| | Female | 9 | 2024 | 73304 | 0.050 |
Why?
| | HLA-A Antigens | 1 | 2022 | 55 | 0.050 |
Why?
| | Myelodysplastic Syndromes | 1 | 2024 | 135 | 0.050 |
Why?
| | Waiting Lists | 1 | 2024 | 266 | 0.050 |
Why?
| | Follow-Up Studies | 2 | 2024 | 5131 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2024 | 7635 | 0.050 |
Why?
| | Adult | 6 | 2024 | 37929 | 0.050 |
Why?
| | Histocompatibility Antigens | 1 | 2022 | 105 | 0.050 |
Why?
| | Male | 8 | 2024 | 67762 | 0.050 |
Why?
| | Cell Line | 3 | 2016 | 2847 | 0.050 |
Why?
| | Catechols | 2 | 2000 | 14 | 0.050 |
Why?
| | Interleukin-2 | 2 | 2000 | 455 | 0.050 |
Why?
| | Hydroquinones | 2 | 2000 | 29 | 0.040 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2022 | 203 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2014 | 3715 | 0.040 |
Why?
| | Aged | 4 | 2024 | 23961 | 0.040 |
Why?
| | Biological Evolution | 1 | 2024 | 474 | 0.040 |
Why?
| | Ligands | 1 | 2022 | 664 | 0.040 |
Why?
| | Young Adult | 3 | 2024 | 13209 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 806 | 0.040 |
Why?
| | Fibroblasts | 2 | 1994 | 996 | 0.040 |
Why?
| | Child, Preschool | 3 | 2024 | 11074 | 0.040 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 152 | 0.040 |
Why?
| | Genotyping Techniques | 1 | 2018 | 75 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2016 | 4193 | 0.030 |
Why?
| | Cell Transplantation | 1 | 1997 | 37 | 0.030 |
Why?
| | Allografts | 1 | 2018 | 146 | 0.030 |
Why?
| | Proinsulin | 1 | 1997 | 54 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2000 | 789 | 0.030 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2016 | 26 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2000 | 965 | 0.030 |
Why?
| | Mesocricetus | 2 | 1992 | 39 | 0.030 |
Why?
| | Collagen Type II | 1 | 2016 | 53 | 0.030 |
Why?
| | Cell Line, Transformed | 2 | 1992 | 145 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2016 | 385 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2016 | 375 | 0.030 |
Why?
| | Genetic Therapy | 1 | 1997 | 297 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2000 | 1242 | 0.030 |
Why?
| | Antigens, Viral, Tumor | 1 | 1994 | 7 | 0.030 |
Why?
| | Tobacco Smoke Pollution | 1 | 1997 | 261 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 730 | 0.030 |
Why?
| | Cell Adhesion | 1 | 1994 | 466 | 0.030 |
Why?
| | Cell Communication | 1 | 1994 | 315 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6079 | 0.020 |
Why?
| | Islets of Langerhans Transplantation | 1 | 1992 | 64 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2016 | 1178 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2016 | 2139 | 0.020 |
Why?
| | Cell Separation | 1 | 1992 | 318 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 2189 | 0.020 |
Why?
| | Autoantibodies | 1 | 2019 | 1496 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 6763 | 0.020 |
Why?
| | DNA | 1 | 1997 | 1459 | 0.020 |
Why?
| | Skin Tests | 1 | 2010 | 101 | 0.020 |
Why?
| | Infant | 1 | 2024 | 9465 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 10811 | 0.020 |
Why?
| | Siblings | 1 | 2010 | 228 | 0.020 |
Why?
| | Glucose | 1 | 1994 | 1020 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 1997 | 1996 | 0.020 |
Why?
| | Ethambutol | 1 | 1987 | 26 | 0.020 |
Why?
| | Rifampin | 1 | 1987 | 84 | 0.020 |
Why?
| | Animals | 5 | 1997 | 36940 | 0.020 |
Why?
| | HLA-B15 Antigen | 1 | 2006 | 13 | 0.020 |
Why?
| | Sequence Homology | 1 | 2006 | 40 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2006 | 297 | 0.010 |
Why?
| | United States | 1 | 2020 | 14841 | 0.010 |
Why?
| | Adolescent | 2 | 2014 | 21513 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2006 | 660 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2010 | 2828 | 0.010 |
Why?
| | Child | 2 | 2014 | 21935 | 0.010 |
Why?
| | Base Sequence | 1 | 2006 | 2181 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2006 | 2900 | 0.010 |
Why?
| | Ganglionic Stimulants | 1 | 2000 | 14 | 0.010 |
Why?
| | Plants, Toxic | 1 | 2000 | 24 | 0.010 |
Why?
| | Genetic Variation | 1 | 2006 | 991 | 0.010 |
Why?
| | Smoke | 1 | 2000 | 141 | 0.010 |
Why?
| | Depression, Chemical | 1 | 1997 | 23 | 0.010 |
Why?
| | Receptors, Transferrin | 1 | 1997 | 24 | 0.010 |
Why?
| | Nicotine | 1 | 2000 | 334 | 0.010 |
Why?
| | 3T3 Cells | 1 | 1997 | 163 | 0.010 |
Why?
| | Insulin, Long-Acting | 1 | 1997 | 63 | 0.010 |
Why?
| | Antioxidants | 1 | 2000 | 584 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1997 | 534 | 0.010 |
Why?
| | Cyclosporine | 1 | 1997 | 268 | 0.010 |
Why?
| | Transplantation, Homologous | 1 | 1997 | 416 | 0.010 |
Why?
| | Mice, Inbred NOD | 1 | 1997 | 601 | 0.010 |
Why?
| | Iron | 1 | 1997 | 313 | 0.010 |
Why?
| | Transfection | 1 | 1997 | 945 | 0.010 |
Why?
| | Cell Survival | 1 | 1997 | 1120 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 1997 | 890 | 0.010 |
Why?
| | RNA | 1 | 1997 | 921 | 0.010 |
Why?
| | Mice | 2 | 1997 | 17787 | 0.010 |
Why?
| | Liver | 1 | 1997 | 1943 | 0.000 |
Why?
| | Blood Glucose | 1 | 1997 | 2186 | 0.000 |
Why?
| | Cell Differentiation | 1 | 1992 | 1991 | 0.000 |
Why?
|
|
Aubrey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|